ストックスクリーナーアプリを入手
106.27
5.12%
-5.73
前日終値:
$112.00
開ける：
$113.68
24時間の取引高:
112.15K
Relative Volume:
0.51
時価総額：
$2.43B
収益：
$249.60M
当期純損益:
$57.73M
株価収益率:
42.27
EPS:
2.5139
ネットキャッシュフロー:
$74.47M
1週間 パフォーマンス:
-0.93%
1か月 パフォーマンス:
-2.65%
6か月 パフォーマンス:
+24.15%
1年 パフォーマンス:
+29.46%
1日の値動き範囲:
$103.22
$115.75
1週間の範囲:
$103.22
$115.75
52週間の値動き範囲:
$78.35
$118.01
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Compare LMAT vs ISRG, BDX, MDLN, ALC, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
106.27 | 2.56B | 249.60M | 57.73M | 74.47M | 2.5139 |
ISRG
Intuitive Surgical Inc
|
449.14 | 159.86B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.44 | 41.01B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
41.39 | 38.32B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
66.56 | 36.29B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
212.14 | 30.15B | 5.40B | 1.49B | 1.78B | 10.12 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-06 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-02-13 | 開始されました | Wells Fargo | Equal Weight |
| 2024-10-15 | 開始されました | Cantor Fitzgerald | Neutral |
| 2024-08-02 | 再開されました | Lake Street | Buy |
| 2024-05-31 | 再開されました | ROTH MKM | Buy |
| 2024-04-26 | アップグレード | Stifel | Hold → Buy |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-09-06 | 開始されました | Oppenheimer | Outperform |
| 2023-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2023-05-03 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | 開始されました | Jefferies | Buy |
| 2021-02-12 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | アップグレード | Sidoti | Neutral → Buy |
| 2019-10-24 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | アップグレード | Lake Street | Hold → Buy |
| 2019-10-14 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | 繰り返されました | Barrington Research | Outperform |
| 2019-07-25 | アップグレード | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | アップグレード | ROTH Capital | Neutral → Buy |
| 2018-06-08 | 再開されました | ROTH Capital | Buy |
| 2018-04-26 | ダウングレード | Stifel | Buy → Hold |
| 2018-04-26 | アップグレード | The Benchmark Company | Hold → Buy |
| 2017-10-27 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2017-07-10 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2017-03-21 | 開始されました | First Analysis Sec | Overweight |
| 2017-02-22 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | ダウングレード | Sidoti | Buy → Neutral |
| 2016-07-28 | 繰り返されました | Barrington Research | Outperform |
| 2016-02-25 | 繰り返されました | Barrington Research | Outperform |
すべてを表示
Lemaitre Vascular Inc (LMAT) 最新ニュース
Wells Fargo & Company Forecasts Strong Price Appreciation for LeMaitre Vascular (NASDAQ:LMAT) Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Declares Quarterly Dividend of $0.25 - MarketBeat
LeMaitre Vascular (LMAT) posts higher Q1 2026 sales, margins and cash flow - Stock Titan
Citizens raises LeMaitre Vascular stock price target on margin outlook By Investing.com - Investing.com Canada
LeMaitre Vascular Q1 Earnings, Sales Rise; Updates 2026 Guidance - marketscreener.com
LeMaitre outlines 2026 targets including $280M revenue and $3 EPS as international Artegraft expands - MSN
LeMaitre Vascular (NASDAQ:LMAT) Issues Earnings Results - MarketBeat
LeMaitre Vascular (LMAT) Reports 11% Q1 Sales Growth, Raises 2026 Guidance, and Declares $0.25 Dividend - Minichart
LeMaitre Vascular Q1 Earnings Call Highlights - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Reports Steady Q1 2026 Results with Earnings Beat and In-Line Revenue - ChartMill
Why LeMaitre Vascular Stock Is Sinking Today - TipRanks
LeMaitre Vascular Sees 2026 Sales $277M-$283M >LMAT - Moomoo
Earnings call transcript: LeMaitre Vascular’s Q1 2026 results beat expectations - Investing.com
LeMaitre Vascular Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
LeMaitre Vascular (LMAT) Tops Q1 Earnings Estimates - Yahoo Finance
LeMaitre Vascular (NASDAQ:LMAT) Issues FY 2026 Earnings Guidance - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Updates Q2 2026 Earnings Guidance - MarketBeat
LeMaitre: Q1 Earnings Snapshot - kare11.com
LeMaitre (NASDAQ:LMAT) Posts Q1 CY2026 Sales In Line With Estimates - Yahoo Finance
LeMaitre Vascular (NASDAQ: LMAT) posts strong Q1 2026 results and raises 2026 growth outlook - Stock Titan
(LMAT) LeMaitre Vascular, Inc. Expects Q2 Revenue Range $70.5M$72.5M - marketscreener.com
Earnings Flash (LMAT) LeMaitre Vascular, Inc. Reports Q1 Revenue $66.6M, vs. FactSet Est of $66.7M - marketscreener.com
BRIEF-LeMaitre Vascular Q1 Sales USD 66.551 Million Vs. IBES Estimate USD 66.5 Million - TradingView
LeMaitre Q1 2026 Financial Results - ChartMill
MSN Money - MSN
LeMaitre Vascular earnings in focus: Can margin gains continue? By Investing.com - Investing.com Australia
LeMaitre Vascular earnings in focus: Can margin gains continue? - Investing.com UK
LeMaitre (LMAT) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
(LMAT) Risk Channels and Responsive Allocation - Stock Traders Daily
How Investors May Respond To LeMaitre Vascular (LMAT) Profit Boost From Strong Operating Leverage - Yahoo Finance
Conestoga Capital Advisors LLC Trims Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular, Inc. $LMAT Shares Acquired by Vest Financial LLC - MarketBeat
Comerica Bank Lowers Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular (LMAT) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Lemaitre Vascular (LMAT) is Strengthening Profitability in Vascular Disease Treatment - Insider Monkey
LeMaitre Vascular Q3 2025 Earnings Preview - MSN
New Strong Buy Stocks for November 14th - MSN
LeMaitre Vascular, Inc. $LMAT Shares Sold by Copeland Capital Management LLC - MarketBeat
Director at LeMaitre Vascular (LMAT) exercises 2,941 share options - Stock Titan
M&T Bank Corp Boosts Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular (LMAT) Stock: Market Direction Signals | Q4 2025: EPS Tops ViewsGuidance Update - Cổng thông tin điện tử Tỉnh Sơn La
LMAT (LeMaitre Vascular Inc.) posts 13.5% YoY Q4 2025 revenue growth, shares fall 2.75% despite mild EPS beat.Trending Buy Opportunities - Cổng thông tin điện tử tỉnh Tây Ninh
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Stock Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
(LMAT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
LMAT SEC FilingsLemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan
Is It Too Late To Consider Buying LeMaitre Vascular (LMAT) After Its Strong Share Price Run? - Yahoo Finance
LeMaitre Vascular (LMAT) Stock: Bullish vs Bearish (+2.43%) 2026-04-18Volatility Breakout - Cổng thông tin điện tử tỉnh Tây Ninh
LMAT Stock Price, Quote & Chart | LEMAITRE VASCULAR INC (NASDAQ:LMAT) - ChartMill
Surgical Equipment & ConsumablesSpecialty Stocks Q4 Earnings: LeMaitre (NASDAQ:LMAT) Firing on All Cylinders - Yahoo Finance
Lemaitre Vascular Inc (LMAT) 財務データ
収益
当期純利益
現金流量
EPS
2.23%
大文字化:
|
ボリューム (24 時間):